Kimberly-Clark's Stock Falls Amid Restructuring Efforts
PorAinvest
jueves, 21 de agosto de 2025, 10:09 am ET1 min de lectura
KMB--
On August 19, 2025, Slocum, Gordon & Co LLP reported selling all 20,789 shares of Kimberly-Clark Corporation (NASDAQ:KMB) during the second quarter. The estimated transaction value, based on the quarterly average price for Q2 2025, was approximately $2.96 million. This move reduced the fund’s position in Kimberly-Clark to zero as of June 30, 2025.
The top holdings after the filing include Procter & Gamble, NextEra Energy, Exxon Mobil, and Merck. Kimberly-Clark shares were priced at $131.33 as of August 18, 2025, with a 1-year price drop of 8.46%. The shares underperformed the S&P 500 by 23.5 percentage points over this period. The company's dividend yield stands at 3.74%, with a forward P/E ratio of 17.34 and an EV/EBITDA (TTM) of 13.0 (as of 2025-06-30). The shares were down 11.9% from their 52-week high as of 2025-08-18.
Kimberly-Clark manufactures and markets personal care and tissue products under brands such as Huggies, Kleenex, and Scott. The company generates revenue primarily through direct sales to supermarkets, mass merchandisers, drugstores, warehouse clubs, and e-commerce platforms, as well as via distributors for both household and away-from-home use. It serves retail consumers globally and commercial clients in sectors including manufacturing, lodging, office buildings, and food service.
References
[1] https://www.marketbeat.com/stocks/NYSE/T/institutional-ownership/
[2] https://www.nasdaq.com/articles/slocum-gordon-exits-stake-kimberly-clark-worth-nearly-3-million
Slocum Gordon & Co LLP sold all 20,789 shares of Kimberly-Clark Corp, valued at approximately $2.96 million, reducing their position to zero as of June 30, 2025. The company's top holdings after the filing include Procter & Gamble, NextEra Energy, Exxon Mobil, and Merck. Kimberly-Clark's shares have underperformed the S&P 500 over the past year, with a 1-year price drop of 8.46%. The company manufactures and markets personal care and tissue products under brands such as Huggies, Kleenex, and Scott.
Title: Slocum Gordon & Co LLP Exits Kimberly-Clark Stake, Reduces Position to ZeroOn August 19, 2025, Slocum, Gordon & Co LLP reported selling all 20,789 shares of Kimberly-Clark Corporation (NASDAQ:KMB) during the second quarter. The estimated transaction value, based on the quarterly average price for Q2 2025, was approximately $2.96 million. This move reduced the fund’s position in Kimberly-Clark to zero as of June 30, 2025.
The top holdings after the filing include Procter & Gamble, NextEra Energy, Exxon Mobil, and Merck. Kimberly-Clark shares were priced at $131.33 as of August 18, 2025, with a 1-year price drop of 8.46%. The shares underperformed the S&P 500 by 23.5 percentage points over this period. The company's dividend yield stands at 3.74%, with a forward P/E ratio of 17.34 and an EV/EBITDA (TTM) of 13.0 (as of 2025-06-30). The shares were down 11.9% from their 52-week high as of 2025-08-18.
Kimberly-Clark manufactures and markets personal care and tissue products under brands such as Huggies, Kleenex, and Scott. The company generates revenue primarily through direct sales to supermarkets, mass merchandisers, drugstores, warehouse clubs, and e-commerce platforms, as well as via distributors for both household and away-from-home use. It serves retail consumers globally and commercial clients in sectors including manufacturing, lodging, office buildings, and food service.
References
[1] https://www.marketbeat.com/stocks/NYSE/T/institutional-ownership/
[2] https://www.nasdaq.com/articles/slocum-gordon-exits-stake-kimberly-clark-worth-nearly-3-million

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios